title: Letter by Damman et al regarding articles, "Long-term cardiovascular mortality after procedure-related or spontaneous myocardial infarction in patients with non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II, ICTUS, and RITA-3 Trials (FIR)" and "American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 Trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38)".
authors.forename: Peter
authors.initials: P
authors.lastname: Damman
authors.forename: Robbert J
authors.initials: RJ
authors.lastname: de Winter
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin
authors.forename: Keith A
authors.initials: KA
authors.lastname: Fox
mesh_terms: D054058:Acute Coronary Syndrome / Q000401:mortality*; D001792:Blood Platelets / Q000187:drug effects*; D001026:Coronary Artery Bypass / Q000401:mortality*; D016757:Death, Sudden, Cardiac / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000401:mortality*; D009204:Myocardial Revascularization / Q000401:mortality*; D010879:Piperazines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013876:Thiophenes / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000379:methods*
chemical_list: D010879:Piperazines; D013876:Thiophenes